BIOMAT Database Logo BIOMAT Database Logo

A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders. 1995

B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Kansas City Veterans Administration Medical Center (151), Kansas City 64128, USA.

This double-blind, placebo-controlled, 6-month follow-up treatment study investigated the efficacy of bromocriptine and nortriptyline in attenuating drinking behavior and psychiatric symptoms in 216 male alcoholic patients subtyped by comorbid psychiatric disorder(s). Three well-defined subtypes were examined: alcoholism only, alcoholism + affective/anxiety disorder, and alcoholism + antisocial personality disorder. It was hypothesized that both medications would relieve negative affective symptoms associated with alcohol use and would be particularly effective for the affective/anxiety subgroup. Contrary to our predictions, the only significant effects found were with the antisocial personality disorder patients who were receiving nortriptyline. One interpretation of the results was that nortriptyline may have reduced impulsive drinking in the antisocial personality disorder subgroup by actions on serotonergic neurotransmission.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009661 Nortriptyline A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions. Desitriptyline,Desmethylamitriptylin,Allegron,Apo-Nortriptyline,Aventyl,Gen-Nortriptyline,Norfenazin,Nortrilen,Nortriptyline Hydrochloride,Novo-Nortriptyline,Nu-Nortriptyline,PMS-Nortriptyline,Pamelor,Paxtibi,ratio-Nortriptyline,Apo Nortriptyline,Gen Nortriptyline,Hydrochloride, Nortriptyline,Novo Nortriptyline,Nu Nortriptyline,PMS Nortriptyline,ratio Nortriptyline
D010555 Personality Inventory Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks. Edwards Personal Preference Schedule,Myers-Briggs Type Indicator,Indicator, Myers-Briggs Type,Inventories, Personality,Inventory, Personality,Myers Briggs Type Indicator,Personality Inventories
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
A double-blind placebo controlled study of male alcoholics given a subcutaneous disulfiram implantation.
June 1987, British journal of addiction,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
January 2013, Journal of orofacial pain,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Bromocriptine in mania--a placebo-controlled double-blind trial.
January 1980, British medical journal,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia.
December 1995, Neurology,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study.
January 1998, Lupus,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Fluphenazine/nortriptyline in the irritable bladder syndrome. A double-blind placebo controlled study.
April 1984, British journal of urology,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Nortriptyline in chronic fatigue syndrome: a double blind, placebo-controlled single case study.
August 1991, Biological psychiatry,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Male hormonal contraception: a double-blind, placebo-controlled study.
July 2008, The Journal of clinical endocrinology and metabolism,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
August 1997, Archives of general psychiatry,
B J Powell, and J L Campbell, and J F Landon, and B I Liskow, and H M Thomas, and E J Nickel, and T M Dale, and E C Penick, and S D Samuelson, and R B Lacoursiere
Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
February 1986, Neurology,
Copied contents to your clipboard!